Let’s start with the hard truth: most co-founders slow you down, most investors want control and a lot of people build companies just because it looks good on LinkedIn, not because they truly believe in their idea. That was never going to be me.

I chose to build my business solo, intentionally. No co-founder, no “advisors” whispering in my ear, no brainstorming sessions dragging on with endless opinions. I didn’t want validation — I wanted speed and clarity.

People often ask, “Isn’t it risky to go it alone?” And I get that. But what’s riskier is handing over your vision to someone else and hoping they protect it with the same fire you have. I had a clear idea of what I wanted to build: a face recognition AI product before the market even caught on, a delivery platform that could grow into a full ecosystem and a wallet that could quietly scale without the usual startup noise.

I wasn’t going to chase capital, wait for permission or explain my vision to people who didn’t get it yet. I wasn’t interested in startup therapy sessions. I wanted results, and I was ready to work for them.

Related: Solopreneurs Are Quietly Building 6 to 7 Figure Empires — Here’s How

The hidden cost of “help”

One of the biggest misconceptions about solo founders is that they have to do everything themselves — that being solo means being small and slow. That couldn’t be further from the truth. I didn’t build a team. I built systems that operated like a well-oiled team.

Every hour wasted costs double when you’re alone, in time and energy. I didn’t have the luxury to figure things out later or wait for others. Everything needed to be lean, fast and repeatable from day one.

For example, I stopped taking endless meetings. Instead, I use Notion to track my decisions, next steps and ideas. It’s like a virtual COO who never forgets. Zapier automates my workflows, connecting apps, notifications and documents without my constant input. Canva and ChatGPT handle design and content without the overhead of a creative team.

Stripe and Google Workspace take care of invoicing, legal paperwork and onboarding — without a single assistant. Calendly manages scheduling, filtering meetings to only what truly matters.

Everything that could be systemized, automated or eliminated was. The goal wasn’t to do every task, but to make sure every task got done without slowing me down. Being solo means being sharp and disciplined, not stretched thin.

Focus only on what moves the needle

The mental game of building alone is often underestimated. It’s not about grinding nonstop or wearing every hat yourself. It’s about ruthless prioritization and protecting your mental energy for decisions only you can make.

I don’t spend hours on technical builds. I delegate development to offshore teams who specialize in what I need and follow the architecture I define. Design is templated and systemized. Admin work is automated or simply cut out.

My job is to think clearly, focus on the strategic and avoid the noise. That means locking in my daily plan the night before, setting a clear delegation process and applying a simple rule: if something takes more than an hour, I either systemize it or hand it off.

The pressure doesn’t come from doing it alone. It comes from trying to be everywhere at once. My edge isn’t that I do everything — it’s that I know exactly what only I can do and make sure everything else moves without me.

Proof comes from action not hype

I didn’t wait for launch day or perfect pitches to validate my ideas. I built quietly in the background and tested where it truly counts — the market.

One early success was a hardware AI concept I developed out of personal passion, not investor pressure. I made a lightweight, plug-and-play face recognition demo, then shared it privately with a few key people who influence adoption and trends.

The result? One buyer signed immediately under an NDA, two more asked for pricing without a formal pitch and the feedback was practical and deep, not surface-level praise.

No press releases, no ad spend, no waiting lists. Just product, context and real customer signals. That was proof enough.

Why I’d still choose to build alone

That early deal wasn’t a one-off. After delivering the proof of concept, I fulfilled the entire solution — negotiating terms, securing deposits and managing production — all without partners or funding. I kept control over every decision and every dollar.

Many assume co-founders or VCs are necessary milestones. I proved they’re not. When you build with clarity, protect your IP and execute with discipline, you don’t need more voices in the room. You need more control.

Building alone gave me confidence, clarity and capital. It let me walk away from one project so I could double down on bigger ones. It’s not about isolation — it’s about focused leverage.

Related: 5 Things You Need to Stop Doing as a Solopreneur

Building a business alone isn’t about a lack of support. It’s about building on your terms. You don’t need to go viral or raise millions to succeed. You need to go all in — with focus, integrity and systems that work while you sleep.

If you’re debating the solo route, remember this: clarity beats consensus. Speed beats committee. Vision beats noise.

Build your way and build it strong.

Ready to break through your revenue ceiling? Join us at Level Up, a conference for ambitious business leaders to unlock new growth opportunities.

Smart professionals aren’t just learning to use AI — they’re using it to take back their time. If your day is filled with repetitive tasks, disjointed workflows, or too many tools that don’t talk to each other, this ChatGPT and Automation E-Degree could be the pivot point you need.

Designed for entrepreneurs, freelancers, and business pros, this $19.97 course bundle covers more than 25 hours of hands-on training across 12 lectures. You’ll go beyond the basics of ChatGPT and explore how more than 20 top AI tools can help you solve real-world challenges in business, marketing, and development.

From building customized GPT workflows to automating routine processes and visualizing data in a more impactful way, the content is tailored to actual use cases, not just theory. You’ll learn how to communicate better with AI tools, use automation to streamline your workload, and even discover how generative AI can help with creativity for your brand or product.

Even better, this deal includes lifetime access. That means you can return to the material whenever you’re ready to tackle a new project or apply what you’ve learned in a new context.

Whether you’re looking to sharpen your tech skills, improve productivity, or future-proof your career, this course helps you get there with tools and strategies you can implement right away.

Grab the full ChatGPT and Automation E-Degree on sale for $19.97 and start building a smarter, faster business.

StackSocial prices subject to change.

Quest Diagnostics (DGX 6.58%) reported its second-quarter 2025 results on July 22, achieving consolidated revenue of $2.76 billion (up 15.2% year over year), organic revenue growth of 5.2%, while adjusted EPS rose 11.5% year over year to $2.62. Management raised full-year revenue guidance to $10.8 billion to $10.92 billion and adjusted EPS to $9.63 to $9.83, citing sustained demand for advanced diagnostics, the integration of last year’s LifeLabs acquisition, and scale-driven productivity gains. Investors should note updated mid-term expectations for growth drivers, operational efficiencies, and regulatory risk exposure discussed below.

Automation drives margin expansion and productivity at DGX

Reported operating income increased to $438 million and adjusted operating income was $466 million, expanding margins by 110 basis points and 30 basis points year over year, respectively, reflecting strategic automation deployments. Cash from operations surged 67.1% year to date to $858 million, aided by a one-time CARES Act tax credit and the timing of receipts and disbursements.

“We have now installed our front-end automation solution, which speeds specimen aliquoting and labeling in half a dozen sites. We also recently completed a successful pilot of our automated accessioning platform at our Clifton lab. We plan to roll out both solutions across our lab network through the rest of the year and into 2026.”
— Jim Davis, Chairman, Chief Executive Officer, and President

Systematic automation rollouts underpin the company’s targeted 3% annual cost and productivity improvement forecast.

LifeLabs acquisition accelerates inorganic revenue growth for Quest Diagnostics

Acquisitions contributed 10% to revenue expansion, with LifeLabs representing approximately 8% of that contribution and producing both procurement and operational synergies.

“We had said operating margin was gonna take a couple of years to get to be on parity with overall enterprise Quest rates. I think we’re tracking to that goal, if not better, you know, and it’s generating the EPS contribution that we expect.”
— Sam Samad, Chief Financial Officer

Strong execution on the LifeLabs integration provides Quest Diagnostics with a scalable Canadian foothold and immediate financial accretion, de-risking its inorganic growth thesis and supporting continued M&A-led expansion.

Regulatory and pricing headwinds remain contained for 2025

Management estimates the company’s exposure to the impact of the “One Big Beautiful Bill” will be limited, with worst-case volume impact sized at 30 to 40 basis points in 2026 and minimal Medicaid-related risk in 2026-2027. Wage inflation held at 3% to 4% for the first half of the year, and the impact of tariffs on China- and Europe-sourced supplies remains within the company’s guidance, and it expects to offset that impact via advance contracting and alternate sourcing efforts.

“For the Medicaid impact, we don’t believe there’s a material impact. We don’t believe there’s any impact in 2026, and an immaterial impact in 2027. For the exchange impact, you know, assuming these subsidies are not renewed at the end of this year, you know, we expect in 2026, approximately 30 basis points of impact on our volumes. That’s what we’ve sized. Obviously, there’s assumptions around that, but that’s what we believe.”
— Sam Samad, Chief Financial Officer

This risk containment supports ongoing guidance confidence.

Looking ahead

Management raised adjusted EPS outlook to a range of $9.63 to $9.83, incorporating 3.5% to 4% organic revenue growth and a 6% to 6.5% M&A contribution. Capital expenditure guidance remains at approximately $500 million, primarily funding Project Nova, with operating margin forecast to expand year over year. The outlook assumes absorption of current tariffs. That guidance does not account for potential new M&A activity or pending legislative changes such as changes to the Protecting Access to Medicare Act.

This article was created using Large Language Models (LLMs) based on The Motley Fool’s insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. The Motley Fool has positions in and recommends Quest Diagnostics. The Motley Fool has a disclosure policy.